NEW YORK (GenomeWeb) – Natera said after the close of the market on Wednesday that its third quarter 2016 revenues climbed 20 percent year over year. 

For the three months ended Sept. 30, the molecular diagnostics firm brought in $53.9 million in revenues compared to $44.9 million in Q3 2015, and beating analysts' average estimate of $48.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.